790 / 1544
EORTC H10
A difference in PFS of 5%
was considered
unacceptable (critics to the
trial design?)
RAPID trial
A difference in PFS of 7%
was considered acceptable
Same OS and most patients
receiving standard salvage
therapy (no ASCT): but more
events are needed to fully
confirm these data
NCRI RAPID and EORTC-GELA-FIL H10
2 trials with similar results but different
interpretations